The management of central venous access device (CVAD) is extremely difficult in babies and small infants (BSI)” Ohno et al (2016).
BACKGROUND: The management of central venous access device (CVAD) is extremely difficult in babies and small infants (BSI). We therefore compared the long-term results and complications of CVAD in BSI with those in children.
ReTweet if useful… Complication rates associated with central venous access devices in infants https://ctt.ec/586Tb+ @ivteam #ivteam
METHODS: One hundred and twenty patients were divided into two groups as follows: age 0.99). The CVAD remained in place for 627 ± 494 and 550 ± 414 days (P = 0.47) and was removed before treatment completion in five and in 14 patients in groups A and B, respectively (P = 0.54).
CONCLUSION: The clinical results for CVAD in BSI did not differ from those in children. CVAD are useful and safe for the treatment of BSI with serious diseases.
Ohno, K., Nakaoka, T., Takama, Y., Higashio, A., Santo, K. and Yoneda, A. (2016) Implantable central venous access device in infants: Long-term results. Pediatrics international. 58(10), p.1027-1031.
Thank you to our partners for supporting IVTEAM